GSK2256294A (GSK 2256294) is a selective and orally active inhibitor of soluble epoxide hydrolase (sEH). GSK2256294A inhibits recombinant human sEH, rat sEH orthologs and murine sEH orthologs with IC50s of 27, 61 and 189 pM, respectively. GSK2256294A can be used for the research of chronic obstructive pulmonary disease (COPD) and cardiovascular disease[1].
Molecular Weight:
447.46
Purity:
99.84
CAS Number:
[1142090-23-0]
Formula:
C21H24F3N7O
Target:
Epoxide Hydrolase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted